Simon May Bio Rad Laboratories, Inc. (BIO) insider trading activity

Simon May is EVP, President, LSG of BIO-RAD LABORATORIES, INC.. Currently has a direct ownership of 3,104 shares of BIO, which is worth approximately $1.14 Million. The most recent transaction as insider was on Sep 04, 2023, when has been sold 295 shares (Bio-Rad A Common Stock) at a price of $394.6 per share, resulting in proceeds of $116,407. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.1K

0% 3M change

0% 12M change

Total Value Held $1.14 Million

SIMON MAY Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 04 2023	SELL Payment of exercise price or tax liability	$116,407 $394.6 p/Share	295 Reduced 8.68%	3,104 Bio-Rad A Common Stock
Sep 04 2023	BUY Exercise of conversion of derivative security	-	600 Added 15.0%	3,399 Bio-Rad A Common Stock
Sep 03 2023	SELL Payment of exercise price or tax liability	$71,817 $394.6 p/Share	182 Reduced 6.11%	2,799 Bio-Rad A Common Stock
Sep 03 2023	BUY Exercise of conversion of derivative security	-	526 Added 15.0%	2,981 Bio-Rad A Common Stock
Sep 02 2023	SELL Payment of exercise price or tax liability	$56,033 $394.6 p/Share	142 Reduced 5.47%	2,455 Bio-Rad A Common Stock
Sep 02 2023	BUY Exercise of conversion of derivative security	-	409 Added 13.61%	2,597 Bio-Rad A Common Stock
Sep 01 2023	SELL Payment of exercise price or tax liability	$121,931 $394.6 p/Share	309 Reduced 12.37%	2,188 Bio-Rad A Common Stock
Sep 01 2023	BUY Exercise of conversion of derivative security	-	891 Added 27.77%	2,317 Bio-Rad A Common Stock
Sep 05 2022	SELL Payment of exercise price or tax liability	$142,539 $478.32 p/Share	298 Reduced 16.13%	1,550 Bio-Rad A Common Stock
Sep 05 2022	BUY Exercise of conversion of derivative security	-	600 Added 24.51%	1,848 Bio-Rad A Common Stock
Sep 04 2022	SELL Payment of exercise price or tax liability	$136,321 $478.32 p/Share	285 Reduced 18.59%	1,248 Bio-Rad A Common Stock
Sep 04 2022	BUY Exercise of conversion of derivative security	-	600 Added 28.13%	1,533 Bio-Rad A Common Stock
Sep 03 2022	SELL Payment of exercise price or tax liability	$87,054 $478.32 p/Share	182 Reduced 16.32%	933 Bio-Rad A Common Stock
Sep 03 2022	BUY Exercise of conversion of derivative security	-	526 Added 32.05%	1,115 Bio-Rad A Common Stock
Sep 02 2022	SELL Payment of exercise price or tax liability	$67,921 $478.32 p/Share	142 Reduced 19.43%	589 Bio-Rad A Common Stock
Sep 02 2022	BUY Exercise of conversion of derivative security	-	409 Added 35.88%	731 Bio-Rad A Common Stock
Sep 01 2022	SELL Payment of exercise price or tax liability	$62,726 $486.25 p/Share	129 Reduced 28.6%	322 Bio-Rad A Common Stock
Sep 01 2022	BUY Exercise of conversion of derivative security	-	371 Added 45.13%	451 Bio-Rad A Common Stock

Also insider at

AGILENT TECHNOLOGIES, INC. Healthcare

Senior Vice President

Simon May

EVP, President, LSG

Hercules, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BIO shares.

Notify only if

Value

Insider Trading

Get notified when an Bio Rad Laboratories, Inc. insider buys or sells BIO shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIO-RAD LABORATORIES, INC.

Track Activities on BIO

Account